|
|
|
|
pmid:
|
Mil'ko ES et al. |
[Production of biologically active compounds by S, R and M forms of Mycobacterium lacticolum on a medium with n-hexadecane]. |
1976 Sep-Oct |
Mikrobiologiia |
pmid:1004267
|
Rabinowitz JL and Hercker ES |
Total plasmalogens and O-(acylalkylglycerophosphoryl) ethanolamine from labelled hexadecanol and palmitate during hypoxia and anoxia in rat heart. |
1976 |
Biochem. J. |
pmid:1016235
|
Flament MP et al. |
Influence of formulation on jet nebulisation quality of alpha 1 protease inhibitor. |
1999 |
Int J Pharm |
pmid:10205630
|
Lu Q et al. |
Synthetic analogues of irlbacholine: a novel antifungal plant metabolite isolated from Irlbachia alata. |
1999 |
J. Nat. Prod. |
pmid:10395496
|
Eckenhoff RG et al. |
Steric hindrance is not required for n-alkanol cutoff in soluble proteins. |
1999 |
Mol. Pharmacol. |
pmid:10419562
|
Gren T and Nyström C |
Porous cellulose matrices containing lipophilic release modifiers--a potential oral extended-release system. |
1999 |
Int J Pharm |
pmid:10425347
|
Zhai H et al. |
Putative skin-protective formulations in preventing and/or inhibiting experimentally-produced irritant and allergic contact dermatitis. |
1999 |
Contact Derm. |
pmid:10515096
|
Sachs S et al. |
Tyloxapol confers durable protection against hyperoxic lung injury in the rat. |
1999 |
Exp. Lung Res. |
pmid:10533679
|
Mano T et al. |
Proton MR spectroscopy of Sjögren-Larsson's syndrome. |
1999 |
AJNR Am J Neuroradiol |
pmid:10543638
|